Terminology for macromolecular derivatives of crosslinked fibrin. On behalf of the Subcommittee on Fibrinogen of the Scientific and Standardization Committee of the ISTH
Mosesson, M.W.
Thrombosis and Haemostasis 73(4): 725-726
1995
ISSN/ISBN: 0340-6245 PMID: 7495086 Document Number: 451662
Document emailed within 1 workday
Related Documents
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Brandt, J.T.; Triplett, D.A.; Alving, B.; Scharrer, I. 1995: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thrombosis and Haemostasis 74(4): 1185-1190
Zacharski, L.R.; Donati, M.B. 1989: Registry of clinical trials of antithrombotic drugs in cancer. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Subcommittee on Hemostasis and Malignancy Thrombosis and Haemostasis 61(3): 526-528
Edwards, R.L.; Silver, J.; Rickles, F.R. 1993: Human tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 69(2): 205-213
van den Besselaar, A.M. 1990: Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 63(2): 316-317
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
von Kries, R.; Hanawa, Y. 1993: Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis Thrombosis and Haemostasis 69(3): 293-295
Asbeck, F.; Lechler, E.; van de Loo, J. 1974: Fibrinogen-fibrin derivatives during difibrase therapy. Detection and course observations of high-molecular and low-molecular derivatives using agarose gel filtration Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1466-1470
Haarsma, M.; Mensi, N.; Roth, M.; Bouvier, C.A. 1974: Immuno-nephelometric characterization of fibrinogen derivatives and of fibrin after chromatography Schweizerische Medizinische Wochenschrift 104(39): 1368-1369
Catanzaro, A.; Edgington, T.S. 1974: The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin Journal of Laboratory and Clinical Medicine 83(3): 458-466
Darling, K. 1986: United States Department of Agriculture statement before the Subcommittee on Investigations and Oversight, Subcommittee on Natural Resources, Agriculture Research and Environment, Subcommittee on Science, Research and Technology, U.S. House of Representatives Committee on Science and Technology, July 23, 1986 Recombinant Dna Technical Bulletin 9(3): 195-202
Gavrish, I.N. 1970: Effect of tryptic hydrolysates of fibrin and fibrinogen on polymerization of monomer fibrin Ukrains'kyi Biokhimichnyi Zhurnal 42(6): 736-742
Krause, W.H.; Maus, W. 1975: The transformation fibrinogen-fibrin in umbilical cord blood. a contribution to fetal fibrinogen Die Medizinische Welt 26(48): 2172-2174
Marchi, R.; Lundberg, U.; de Bosch, N.B.; Arocha-Piñango, C.L. 1998: Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(8): 733-739
Elms, M.J.; Bunce, I.H.; Bundesen, P.G.; Rylatt, D.B.; Webber, A.J.; Masci, P.P.; Whitaker, A.N. 1983: Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies Thrombosis and Haemostasis 50(2): 591-594
Jirousková, M.; Smyth, S.S.; Kudryk, B.; Coller, B.S. 2001: A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis Thrombosis and Haemostasis 86(4): 1047-1056
1971: American Academy of Pediatrics Committee on Environmental Hazards and Subcommittee on Accidental Poisoning of Committee on Accident Prevention. Acute and chronic childhood lead poisoning Pediatrics 47(5): 950-951
Abrams, P.; Blaivas, J.G.; Stanton, S.L.; Andersen, J.T. 1988: The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology Scandinavian Journal of Urology and Nephrology. Supplementum 114: 5-19
Platonova, T.N.; Musialkovskaia, A.A.; Tolstykh, V.M.; Belitser, V.A. 1980: Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition Biokhimiia 45(10): 1780-1787